These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8596554)
1. Growth hormone for heart failure--cause for cautious optimism. Loh E; Swain JL N Engl J Med; 1996 Mar; 334(13):856-7. PubMed ID: 8596554 [No Abstract] [Full Text] [Related]
2. Growth hormone in the treatment of dilated cardiomyopathy. Turner H; Wass JA N Engl J Med; 1996 Aug; 335(9):672; author reply 673-4. PubMed ID: 8692249 [No Abstract] [Full Text] [Related]
3. Growth hormone in the treatment of dilated cardiomyopathy. Frustaci A; Gentiloni N; Russo MA N Engl J Med; 1996 Aug; 335(9):672-3; author reply 673-4. PubMed ID: 8692248 [No Abstract] [Full Text] [Related]
4. Growth hormone therapy in patients with dilated cardiomyopathy: preliminary observations of a pilot study. Jose VJ; Zechariah TU; George P; Jonathan V Indian Heart J; 1999; 51(2):183-5. PubMed ID: 10407547 [TBL] [Abstract][Full Text] [Related]
5. [Growth hormone and dilated cardiomyopathy]. Dreifuss P Dtsch Med Wochenschr; 2002 Jun; 127(23):1261-3. PubMed ID: 12053286 [No Abstract] [Full Text] [Related]
6. Morphometry and GH/IGF-1 axis deficiency may identify a form of dilated cardiomyopathy which is corrected by recombinant human growth hormone (rHGH). Frustaci A; Zurlo A; Perrone GA; Russo A; Caldarulo M; Russo MA Ann N Y Acad Sci; 1995 Mar; 752():422-5. PubMed ID: 7755286 [No Abstract] [Full Text] [Related]
7. [Therapy of dilated cardiomyopathy with recombinant human growth hormone]. Osterziel KJ; Markus U; Willenbrock R; Strohm O; Dietz R Z Kardiol; 1997 Oct; 86(10):803-11. PubMed ID: 9454447 [TBL] [Abstract][Full Text] [Related]
8. The growth hormone IGF-I axis in dilated cardiomyopathy. Jenkins RC; Ross RJ Clin Endocrinol (Oxf); 1999 Apr; 50(4):415-6. PubMed ID: 10468899 [No Abstract] [Full Text] [Related]
13. Reversible dilated cardiomyopathy due to growth hormone deficiency. Cuneo R; Salomon F; Wilmshurst P; Lowy C; McGauley G; Sonksen P Am J Clin Pathol; 1993 Nov; 100(5):585-6. PubMed ID: 8249901 [No Abstract] [Full Text] [Related]
14. [Use of recombinant growth hormone in children with kidney failure]. Broyer M; Rappaport R Arch Pediatr; 1994 Aug; 1(8):706-8. PubMed ID: 7842102 [No Abstract] [Full Text] [Related]
16. Cardiac effects of growth hormone. Dreifuss P Circulation; 2004 Jun; 109(25):e332. PubMed ID: 15226241 [No Abstract] [Full Text] [Related]
17. The use of human recombinant growth hormone for treatment of growth failure in uremia. Mehls O; Fine RN Semin Nephrol; 1989 Mar; 9(1):43-8. PubMed ID: 2662300 [No Abstract] [Full Text] [Related]
18. Treatment of growth failure in renal disease with recombinant human growth hormone: 2 years' experience. Tönshoff B; Mehls O Dev Pharmacol Ther; 1992; 18(3-4):171-3. PubMed ID: 1306805 [No Abstract] [Full Text] [Related]
19. Reversing idiopathic dilated cardiomyopathy with growth hormone: is this possible? de Luis Román D; Romero Bobillo E Ann Intern Med; 1997 May; 126(10):834. PubMed ID: 9148673 [No Abstract] [Full Text] [Related]
20. [Growth hormone: effect on bone metabolism and bone density]. Kann P; Piepkorn B; Schehler B; Andreas J; Lotz J; Bockisch A; Prellwitz W; Beyer J Med Klin (Munich); 1996 Feb; 91 Suppl 1():46-9. PubMed ID: 8839117 [No Abstract] [Full Text] [Related] [Next] [New Search]